217 related articles for article (PubMed ID: 19711376)
21. A lectin-coupled, targeted proteomic mass spectrometry (MRM MS) platform for identification of multiple liver cancer biomarkers in human plasma.
Ahn YH; Shin PM; Oh NR; Park GW; Kim H; Yoo JS
J Proteomics; 2012 Sep; 75(17):5507-15. PubMed ID: 22789673
[TBL] [Abstract][Full Text] [Related]
22. Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot.
Qiu Y; Patwa TH; Xu L; Shedden K; Misek DE; Tuck M; Jin G; Ruffin MT; Turgeon DK; Synal S; Bresalier R; Marcon N; Brenner DE; Lubman DM
J Proteome Res; 2008 Apr; 7(4):1693-703. PubMed ID: 18311904
[TBL] [Abstract][Full Text] [Related]
23. Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study.
Nakamura N; Hatano E; Iguchi K; Sato M; Kawaguchi H; Ohtsu I; Sakurai T; Aizawa N; Iijima H; Nishiguchi S; Tomono T; Okuda Y; Wada S; Seo S; Taura K; Uemoto S; Ikegawa M
BMC Cancer; 2019 Jun; 19(1):621. PubMed ID: 31238892
[TBL] [Abstract][Full Text] [Related]
24. Multiplex profiling of glycoproteins using a novel bead-based lectin array.
Wang H; Li H; Zhang W; Wei L; Yu H; Yang P
Proteomics; 2014 Jan; 14(1):78-86. PubMed ID: 24243643
[TBL] [Abstract][Full Text] [Related]
25. Identification and analysis of alpha1,6-fucosylated proteins in human normal liver tissues by a target glycoproteomic approach.
Dai Z; Fan J; Liu Y; Zhou J; Bai D; Tan C; Guo K; Zhang Y; Zhao Y; Yang P
Electrophoresis; 2007 Dec; 28(23):4382-91. PubMed ID: 18041034
[TBL] [Abstract][Full Text] [Related]
26. Identification and confirmation of biomarkers using an integrated platform for quantitative analysis of glycoproteins and their glycosylations.
Liu Y; He J; Li C; Benitez R; Fu S; Marrero J; Lubman DM
J Proteome Res; 2010 Feb; 9(2):798-805. PubMed ID: 19961239
[TBL] [Abstract][Full Text] [Related]
27. Alteration of N-glycan expression profile and glycan pattern of glycoproteins in human hepatoma cells after HCV infection.
Xiang T; Yang G; Liu X; Zhou Y; Fu Z; Lu F; Gu J; Taniguchi N; Tan Z; Chen X; Xie Y; Guan F; Zhang XL
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1036-1045. PubMed ID: 28229927
[TBL] [Abstract][Full Text] [Related]
28. Highly enhanced fucosylation of serum glycoproteins in patients with hepatocellular carcinoma.
Naitoh A; Aoyagi Y; Asakura H
J Gastroenterol Hepatol; 1999 May; 14(5):436-45. PubMed ID: 10355508
[TBL] [Abstract][Full Text] [Related]
29. High-throughput lectin magnetic bead array-coupled tandem mass spectrometry for glycoprotein biomarker discovery.
Choi E; Loo D; Dennis JW; O'Leary CA; Hill MM
Electrophoresis; 2011 Dec; 32(24):3564-75. PubMed ID: 22180208
[TBL] [Abstract][Full Text] [Related]
30. Lectin magnetic bead array for biomarker discovery.
Loo D; Jones A; Hill MM
J Proteome Res; 2010 Oct; 9(10):5496-500. PubMed ID: 20726593
[TBL] [Abstract][Full Text] [Related]
31. Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma.
Comunale MA; Rodemich-Betesh L; Hafner J; Wang M; Norton P; Di Bisceglie AM; Block T; Mehta A
PLoS One; 2010 Aug; 5(8):e12419. PubMed ID: 20811639
[TBL] [Abstract][Full Text] [Related]
32. Analysis of MALDI-TOF mass spectrometry data for discovery of peptide and glycan biomarkers of hepatocellular carcinoma.
Ressom HW; Varghese RS; Goldman L; An Y; Loffredo CA; Abdel-Hamid M; Kyselova Z; Mechref Y; Novotny M; Drake SK; Goldman R
J Proteome Res; 2008 Feb; 7(2):603-10. PubMed ID: 18189345
[TBL] [Abstract][Full Text] [Related]
33. Glycoproteomic analysis by two-dimensional electrophoresis.
Comunale MA; Mehta A
Methods Mol Biol; 2009; 520():59-74. PubMed ID: 19381947
[TBL] [Abstract][Full Text] [Related]
34. Glycoproteomic Alterations in Drug-Resistant Nonsmall Cell Lung Cancer Cells Revealed by Lectin Magnetic Nanoprobe-Based Mass Spectrometry.
Waniwan JT; Chen YJ; Capangpangan R; Weng SH; Chen YJ
J Proteome Res; 2018 Nov; 17(11):3761-3773. PubMed ID: 30261726
[TBL] [Abstract][Full Text] [Related]
35. Identification of unique glycoisoforms of vitamin D-binding protein and haptoglobin as biomarker candidates in hepatocarcinogenesis of STAM mice.
Yoshida Y; Furukawa JI; Naito S; Higashino K; Numata Y; Shinohara Y
Glycoconj J; 2018 Oct; 35(5):467-476. PubMed ID: 30194503
[TBL] [Abstract][Full Text] [Related]
36. Identification of O-Linked Glycoproteins Binding to the Lectin Helix pomatia Agglutinin as Markers of Metastatic Colorectal Cancer.
Peiris D; Ossondo M; Fry S; Loizidou M; Smith-Ravin J; Dwek MV
PLoS One; 2015; 10(10):e0138345. PubMed ID: 26495974
[TBL] [Abstract][Full Text] [Related]
37. Raman based hepatocellular carcinoma biomarker detection.
Santiago-Cordoba MA; Romano PR; MacKay A; Demirel MC
Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():3672-5. PubMed ID: 22255136
[TBL] [Abstract][Full Text] [Related]
38. GPSeeker Enables Quantitative Structural N-Glycoproteomics for Site- and Structure-Specific Characterization of Differentially Expressed N-Glycosylation in Hepatocellular Carcinoma.
Xiao K; Tian Z
J Proteome Res; 2019 Jul; 18(7):2885-2895. PubMed ID: 31117584
[TBL] [Abstract][Full Text] [Related]
39. Identification of sialylated glycoproteins in Doxorubicin-treated hepatoma cells with glycoproteomic analyses.
Azuma K; Serada S; Takamatsu S; Terao N; Takeishi S; Kamada Y; Naka T; Miyoshi E
J Proteome Res; 2014 Nov; 13(11):4869-77. PubMed ID: 25158113
[TBL] [Abstract][Full Text] [Related]
40. Multiple lectin assays for detecting glyco-alteration of serum GP73 in liver diseases.
Jiang K; Shang S; Li W; Guo K; Qin X; Zhang S; Liu Y
Glycoconj J; 2015 Dec; 32(9):657-64. PubMed ID: 26342810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
